NeuroBo Pharmaceuticals, Inc. (NRBO), a clinical-stage biotechnology company, Thursday said it has submitted Investigational New Drug or IND application to FDA, regarding Phase 1 clinical trial of DA-1726 for the treatment of obesity.
from RTT - Before the Bell https://ift.tt/07JzYSc
via IFTTT
No comments:
Post a Comment